In comparison to Semaglutide and Tirzepatide, retatrutide's unique inclusion of glucagon receptor agonism along with GIP and GLP-1 receptor agonism presents a distinct pharmacological profile. When Semaglutide can be a GLP-1 receptor agonist and Tirzepatide brings together GLP-1 and GIP receptor agonism, retatrutide's triple system could potentially offer broader metabolic https://soichirou468dls1.wikiitemization.com/user